DRUG · Mapped RxNorm record
Memantine
Normalized identity: memantineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
NCT00505167
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Donepezil
Normalized identity: donepezilView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMemantine Versus Donepezil in Early Stages of Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Dementia, Alzheimer Typeunresolved
Interventions
MemantineDRUG · verified · RxNorm: memantine
DonepezilDRUG · verified · RxNorm: donepezil
Sponsors & collaborators
Hospital Miguel Servetlead sponsor
Clinica Quiron de Zaragozacollaborator
Universidad de Zaragozacollaborator
Hospital de Barbastrocollaborator
Hospital Universitario Royo Villanovacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00505167 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.